A mouse study found that a brief period of starvation made anti–PD-1 immunotherapy substantially more effective against lung cancer.

Ajona and colleagues (2020) combined short-term starvation (STS) with PD-1 blockade in mouse models of lung cancer. The combined treatment suppressed tumor progression and metastatic spread more effectively than either treatment alone.
The investigators linked the effect to reduced circulating IGF-1 and weaker IGF-1 receptor signaling in tumor cells. CD8 T cells were required for the antitumor response, demonstrating that this was not simply a matter of restricting fuel to cancer cells.
The striking observation is that a brief systemic metabolic intervention changed the effectiveness of an immune treatment. Whether Therapeutic Hypoglycemia could reproduce any of these effects is a separate question.
Source: Ajona et al. (2020), Nature Cancer, doi:10.1038/s43018-019-0007-9.
